Skip to content

Clinical trials

Observational Liver Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Neoplasms Phase: Observational Country / region: Germany Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20172
20183
20193
20203
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated4
Recruiting3
Active, not recruiting1
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer1
Ethicon, Inc.1
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1
Ludwig-Maximilians - University of Munich1
Maastricht University Medical Center1
Prof. Valérie Mc Lin1
Royal Free Hospital NHS Foundation Trust1
Seoul National University Hospital1
Target PharmaSolutions, Inc.1
UMC Utrecht1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Neoplasms14
Carcinoma, Hepatocellular5
Cholangiocarcinoma3
Esophageal Neoplasms3
Pancreatic Neoplasms3
Liver Diseases2
Rectal Neoplasms2
Stomach Neoplasms2
Bile Duct Neoplasms1
Brain Neoplasms1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.